D-0643-2025 Class II Ongoing

Recalled by AvKARE — Pulaski, TN

FDA drug recall D-0643-2025 was initiated by AvKARE on Aug 25, 2025 and is designated Class II. Reason for recall: Presence of a foreign substance. The recall status is ongoing. Affected quantity: 1512 cartons.

Recall details

Product Type
Drugs
Report Date
Sep 17, 2025
Initiation Date
Aug 25, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1512 cartons

Product description

chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-164-15

Reason for recall

Presence of a foreign substance.

Distribution pattern

USA Nationwide

Code information

Lot # 46824, Exp 9/30/25; 47171, Exp 12/31/25

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0643-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0643-2025. Report a data issue: hello@regdatalab.com.